Eclanamine maleate
| Code | Size | Price |
|---|
| TAR-T31601-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T31601-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T31601-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Eclanamine was discovered to be slightly mutagenic in the AS52 assay, and a potential agent which was subjected to a battery of short-term assays for genetic activity.
CAS:
67450-45-7
Formula:
C20H26Cl2N2O5
Molecular Weight:
445.34
Purity:
0.98
SMILES:
OC(=O)C=C/C(O)=O.CCC(=O)N([C@@H]1CCC[C@H]1N(C)C)c1ccc(Cl)c(Cl)c1
References
1. Aaron CS, Harbach PR, Mattano SS, Mayo JK, Wang Y, Yu RL, Zimmer DM. Risk and benefit evaluation in development of pharmaceutical products. Environ Health Perspect. 1993 Oct;101 Suppl 3:291-5. Review. PubMed PMID: 8143634; PubMed Central PMCID: PMC1521120.
2. Aaron CS, Stankowski LF Jr, Harbach PR, Valencia R, Mayo JK, Mirsalis J, Mazurek JH, Steinmetz KL, Wiser SK, Zimmer DM, et al. Comparative mutagenicity testing of a drug candidate, U-48753E: mechanism of induction of gene mutations in mammalian cells and quantitation of potential hazard. Mutat Res. 1989 Jun;223(2):111-20. PubMed PMID: 2500592.
3. Sethy VH, Day JS, Cooper MM. Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):673-82. PubMed PMID: 2851860.